Orchid Pharma Limited (NSE:ORCHPHARMA)
India · Delayed Price · Currency is INR 983.45
-13.55 (-1.36%)
Oct 1, 2026, 3:30 PM IST
Orchid Pharma Market Cap
Orchid Pharma has a market cap or net worth of 50.21 billion as of October 1, 2026. Its market cap has increased by 41.03% in one year.
Market Cap
50.21B
Enterprise Value
53.01B
Revenue
8.52B
Ranking
n/a
PE Ratio
170.29
Stock Price
983.45
ChartMarket Cap Chart
Since November 3, 2020, Orchid Pharma's market cap has increased from 727.35M to 50.21B, an increase of 6,803.42%. That is a compound annual growth rate of 104.67%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 1, 2026 | 50.21B | 30.44% |
| Dec 31, 2025 | 38.49B | -58.00% |
| Dec 31, 2024 | 91.65B | 153.62% |
| Dec 29, 2023 | 36.14B | 143.20% |
| Dec 30, 2022 | 14.86B | -7.81% |
| Dec 31, 2021 | 16.12B | 223.64% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Nov 3, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Akums Drugs and Pharmaceuticals | 125.47B |
| Strides Pharma Science | 108.08B |
| Aarti Pharmalabs | 88.21B |
| Innova Captab | 72.74B |
| Sun Pharma Advanced Research Company | 65.83B |
| RPG Life Sciences | 51.09B |
| Solara Active Pharma Sciences | 36.18B |
| Ind-Swift Laboratories | 35.92B |